Mary J. Waskerwitz

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

D G Tubergen, Gerald S. Gilchrist, Richard T. O’Brien et al. · Journal of Clinical Oncology · 1993 · 225 citations

Medicine, Oncology, Pediatrics +15

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

D G Tubergen, Gerald S. Gilchrist, Richard T. O’Brien et al. · Journal of Clinical Oncology · 1993 · 153 citations

Medicine, Oncology, Pediatrics +14

Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children’s Cancer Group and Pediatric Oncology Branch Study

Frank M. Balis, John S. Holcenberg, David G. Poplack et al. · Blood · 1998 · 112 citations

Medicine, Pharmacokinetics, Pharmacology +15

Risk factors for Wilms tumor: Report from the national Wilms tumor study

Andrew F. Olshan, Norman E. Breslow, John M. Falletta et al. · Cancer · 1993 · 86 citations

Medicine, Child Health, Oncology +17

Behavioral Adkjustmnet and Social Functioning of Long-Term, Survivors of Childhood Leukemia: Parent and Teacher Reports

Robert B. Noll, Willaim E. MachLean, J. Keneth Whitt et al. · Journal of Pediatric Psychology · 1997 · 80 citations · Full text

Medicine, Oncology, Pediatrics +17